Ms. Lewis joined Kura in November 2020 as Vice President, Quality Assurance with more than 27 years of pharmaceutical, biologics and medical device experience. She has served in a number of roles focused on managing quality assurance across multiple biotech and pharmaceutical companies. Most recently, she was Vice President of Quality Assurance for La Jolla Pharmaceutical Company, where she managed the quality systems to the standards expected by US and EU regulatory authorities to support development and commercial activities. Prior to La Jolla Pharmaceutical Company, Ms. Lewis served as the Sr. Director and Head of Quality Assurance for Regulus Therapeutics Inc. and Apricus Biosciences, Inc. Ms. Lewis also has been a Quality consultant for the industry. Ms. Lewis received her B.A. in Chemistry at the University of San Diego.